The frequency of epileptic seizures was significantly decreased in the rufinamide group than in the placebo group ; the median percent change in frequency of tonic-atonic seizures was -24.2 % and -3.3 % , respectively , ( p = 0.003 ) and that of total seizures was -32.9 % and -3.1 % , respectively ( p < 0.001 ) .